Model health care reform on Medicare Part D

  • by: |
  • 10/29/2009
Model health care reform on Medicare Part D

Mercury News
By Peter Pitts
10/27/2009
 
Democrats who think their leading health care proposals might actually get passed are fooling themselves. Opposition to their agenda isn't isolated to a few town hall meetings and protests. It's widespread across the country. A recent Rasmussen poll found that a whopping 56 percent of Americans are against the Democratic reform legislation.
 
It's time to go back to the drawing board. The president and Congress need to craft a brand new, moderate health plan that consists of practically minded proposals capable of generating broad support across both parties.
 
The primary goal of a revamped bill should be bringing down costs, which poll after poll finds is the primary concern of most Americans when it comes to health care. Recent political developments have laid the groundwork for just such a bill.
 
Rep. Bill Cassidy, R-La., told a talk radio program last month that Blue Dog Democrats — a coalition of 52 moderate Democratic members in the House — have been reaching out to him and other Republicans to negotiate alternative health care legislation. Cassidy explained: "Some of my Democratic colleagues are approaching me now, saying we are not going to vote for H.R. 3200 (the main Democratic House bill); can we talk about some of our ideas."
 
Americans balked at the current slate of Democratic reforms because they're government-heavy and expensive. Sen. Max Baucus' bill, for instance, comes with an $856 billion price tag and institutes expansive new regulatory controls on insurers, caregivers and patients.
 
Health care reform is needed. Radical reform is not. Therefore, lawmakers' best bet is to build on existing programs already proven to succeed. The best example of such a program is Medicare Part D, the federal prescription drug coverage program for seniors. Part D has an innovative structure: private insurers administer the plans, while the government provides cost subsidies.
 
Created in 2006, Part D has proved to be one of the most popular and successful government programs ever. The competition among insurers for customers has led to significantly lower drug prices for beneficiaries. In fact, the total cost of Part D is nearly a third lower than initial budget projections. Seniors get to choose among dozens of competing plans, customizing their coverage to fit their particular medical and financial needs.
 
Part D has a 92 percent satisfaction rate among its beneficiaries. And the program has reduced the number of seniors without a drug plan by 17 percent. It provides a road map for how to expand coverage in this country without drastic government intervention in the health care sector.
 
Today, there are 8 million to 15 million chronically uninsured Americans who are priced out of the private insurance market but don't qualify for government assistance. These people undoubtedly need help. Instead of radically reshaping nearly 20 percent of the U.S. economy, lawmakers should create a new health insurance program modeled on Part D open to this vulnerable population. The plans would be privately administered but publicly subsidized, and customers could choose the coverage that's best for them.
 
Congress and the president need to craft new legislation that actually addresses the insurance needs of the American people and is based on the kind of post-partisan cooperation Obama promised in the campaign. A new insurance program modeled on Part D could unleash competitive forces that have already proven to drive down costs and expand coverage.

PETER J. PITTS is president of the Center for Medicine in the Public Interest and a former FDA Associate Commissioner.
CMPI

Center for Medicine in the Public Interest is a nonprofit, non-partisan organization promoting innovative solutions that advance medical progress, reduce health disparities, extend life and make health care more affordable, preventive and patient-centered. CMPI also provides the public, policymakers and the media a reliable source of independent scientific analysis on issues ranging from personalized medicine, food and drug safety, health care reform and comparative effectiveness.

Blog Roll

Alliance for Patient Access Alternative Health Practice
AHRP
Better Health
BigGovHealth
Biotech Blog
BrandweekNRX
CA Medicine man
Cafe Pharma
Campaign for Modern Medicines
Carlat Psychiatry Blog
Clinical Psychology and Psychiatry: A Closer Look
Conservative's Forum
Club For Growth
CNEhealth.org
Diabetes Mine
Disruptive Women
Doctors For Patient Care
Dr. Gov
Drug Channels
DTC Perspectives
eDrugSearch
Envisioning 2.0
EyeOnFDA
FDA Law Blog
Fierce Pharma
fightingdiseases.org
Fresh Air Fund
Furious Seasons
Gooznews
Gel Health News
Hands Off My Health
Health Business Blog
Health Care BS
Health Care for All
Healthy Skepticism
Hooked: Ethics, Medicine, and Pharma
Hugh Hewitt
IgniteBlog
In the Pipeline
In Vivo
Instapundit
Internet Drug News
Jaz'd Healthcare
Jaz'd Pharmaceutical Industry
Jim Edwards' NRx
Kaus Files
KevinMD
Laffer Health Care Report
Little Green Footballs
Med Buzz
Media Research Center
Medrants
More than Medicine
National Review
Neuroethics & Law
Newsbusters
Nurses For Reform
Nurses For Reform Blog
Opinion Journal
Orange Book
PAL
Peter Rost
Pharm Aid
Pharma Blog Review
Pharma Blogsphere
Pharma Marketing Blog
Pharmablogger
Pharmacology Corner
Pharmagossip
Pharmamotion
Pharmalot
Pharmaceutical Business Review
Piper Report
Polipundit
Powerline
Prescription for a Cure
Public Plan Facts
Quackwatch
Real Clear Politics
Remedyhealthcare
Shark Report
Shearlings Got Plowed
StateHouseCall.org
Taking Back America
Terra Sigillata
The Cycle
The Catalyst
The Lonely Conservative
TortsProf
Town Hall
Washington Monthly
World of DTC Marketing
WSJ Health Blog